Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity

Trends in Cardiovascular Medicine

Volumn 10, Issue 2, 2000, Pages 60-65

  Pillarisetti, Sivaram ^b  

^a Reddy US Therapeutics   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HEPARANASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PERLECAN; PROTEOHEPARAN SULFATE;

ATHEROGENESIS; BASEMENT MEMBRANE; CELL ADHESION; CELL GROWTH; ENDOTHELIUM CELL; ENZYME RELEASE; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LIPOPROTEINS; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034529045     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(00)00048-7     Document Type: Review

References (46)

1. Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells
2. Cell adhesion molecules, signal transduction and cell growth
3. Perlecan is essential for cartilage and cephalic development
4. Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro; implications for a role of heparinase like enzymes in the neovascular response
5. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neo intimal formation in vivo
6. Characterization of proteoglycans synthesized by cultured corneal fibroblasts in response to transforming growth factor beta and fetal calf serum
7. Perlecan maintains the integrity of cartilage and some basement membranes
8. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells
9. Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis
10. NO generating vasodilators and 8 bromo cGMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
11. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins; an adhesion modulated by glycosaminoglycan
12. Relationship of sulfated glycosaminoglycans and cholesterol content in normal and atherosclerotic human aorta
13. Interaction of native and cell-modified low density lipoprotein with collagen gel
14. Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells
15. Cellular consequences of the association of apoB lipoproteins with proteoglycans
16. The biology of perlecan
17. Structural characterization of perlecan gene promoter
18. Apolipoprotein E inhibits vascular smooth muscle cell proliferation and migration by activating NO synthase and inhibiting MAP kinase
19. Pathogenesis of diabetic vascular disease; evidence for the role of reduced heparan sulfate proteoglycan
20. Oxidized lipoproteins and nitric oxide
21. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis
22. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells
23. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1
24. More to heparin than anticoagulation
25. Oxidized LDL activates STAT1 and STAT3 transcription factors; possible involvement of reactive oxygen species
26. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells
27. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells
28. Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth
29. Apo E stimulates endothelial production heparan sulfate rich in biologically active heparin-like domains
30. Lysolecithin induced alterations of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix
31. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein (a) retention by subendothelial matrix
32. Perturbation of the blood-retinal barrier after enzyme perfusion. A cytochemical study
33. Oxidized lipid-mediated alterations in proteoglycan metabolism in cultured pulmonary endothelial cells
34. Heparan sulfate proteoglycans of vascular system
35. Atherosclerosis; an inflammatory disease
36. Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells
37. Initiation of atherosclerotic lesion in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries
38. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation
39. Transcriptional silencing of perlecan gene expression by interferon γ
40. Binding of recombinant apo(a) to extracellular matrix proteins
41. Mammalian heparanase; gene cloning, expression and function in tumor progression and metastasis
42. Developmental regulation of perlecan gene expression in aortic smooth muscle cells
43. The extracellular matrix and atherosclerosis
44. Synergistic activators of cell adhesion
45. Heparin regulates endothelin production through endothelium derived nitric oxide in human endothelial cells